Bioventus (BVS) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Bioventus Reports Second Quarter Financial Results • Q2 Revenue Advanced by 10.3%, Organic Growth* by 13.9% • Q2 Gross Margin Expanded 350 bps and Adjusted Gross Margin* 180 bps • Cash from Operations of $15.2 million Increased 40.5% • Raising Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic Priorities DURHAM, NC – August 6, 2024 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, ...